Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 216

The DOI matches its Crossref record.

Growth factor involvement in progression of prostate cancer

Russell, Pamela J, Bennett, Suzanne, Stricker, Phillip·1998·Clinical Chemistry
DOI 10.1093/clinchem/44.4.705
Open this paper in CoChat — free account

Abstract

Understanding how the regulation of growth factor pathways alters during prostate cancer (PC) progression may enable researchers to develop targeted therapeutic strategies for advanced disease. PC progression involves the shifting of cells from androgen-dependent growth to an androgen-independent state, sometimes with the loss or mutation of the androgen receptors in PC cells. Both autocrine and paracrine pathways are up-regulated in androgen-independent tumors and may replace androgens as primary growth stimulatory factors in cancer progression. Our discussion focuses on growth factor families that maintain homeostasis between epithelial and stromal cells in the normal prostate and that undergo changes as PC progresses, often making stromal cells redundant. These growth factors include fibroblast growth factor, insulin-like growth factors, epidermal growth factor, transforming growth factor α, retinoic acid, vitamin D3, and the transforming growth factor β families. We review their role in normal prostate development and in cancer progression, using evidence from clinical specimens and models of PC cell growth.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/clinchem/44.4.705

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 228

  1. 1985, Cancer J Clin, 35, 36, 10.3322/canjclin.35.1.36 · DOI · Paper page
  2. 1994, Incidence and Mortality, 58
  3. 1990, Cancer J Clin, 44, 7
  4. 1986, Lancet, i, 60
  5. 1995, Urology, 46, 757, 10.1016/S0090-4295(99)80339-2 · DOI
  6. 1994, Urology, 43, 60, 10.1016/S0090-4295(94)80264-5 · doi:10.1016/s0090-4295(94)80264-5
  7. 1993, J Urol, 150, 400, 10.1016/S0022-5347(17)35493-9 · doi:10.1016/s0022-5347(17)35493-9
  8. 1994, N Engl J Med, 330, 242, 10.1056/NEJM199401273300403 · DOI · Paper page
  9. 1993, Prostate diseases, 28
  10. 1996, Prostate, 28, 98, 10.1002/(SICI)1097-0045(199602)28:2<98::AID-PROS4>3.0.CO;2-J · DOI · Paper page
  11. 1992, Campbell’s urology, 221
  12. 1987, Endocr Rev, 8, 338, 10.1210/edrv-8-3-338 · DOI · Paper page
  13. 1997, Principles and practice of genitourinary oncology, 367
  14. 1994, N Engl J Med, 331, 996, 10.1056/NEJM199410133311507 · DOI · Paper page
  15. 1988, Mol Endocrinol, 2, 1265, 10.1210/mend-2-12-1265 · DOI · Paper page
  16. 1996, Prostate, 6, 52
  17. 1991, Cancer Surv, 11, 91
  18. 1991, Cancer, 67, 3057, 10.1002/1097-0142(19910615)67:12<3057::AID-CNCR2820671221>3.0.CO;2-S · DOI
  19. 1992, J Urol, 147, 798, 10.1016/S0022-5347(17)37389-5 · DOI
  20. 1996, J Endocrinol, 151, 1, 10.1677/joe.0.1510001 · DOI
  21. 1995, N Engl J Med, 332, 1393, 10.1056/NEJM199505253322101 · DOI · Paper page
  22. 1994, Cancer Res, 54, 2861
  23. 1990, Biochim Biophys Acta, 1052, 187, 10.1016/0167-4889(90)90075-O · DOI · Paper page
  24. 1994, Biochem Biophys Res Commun, 198, 74, 10.1006/bbrc.1994.1011 · DOI · Paper page
  25. 1990, Mol Endocrinol, 4, 7211
  26. 1991, J Biol Chem, 226, 510
  27. 1994, Cancer Res, 54, 5474
  28. 1988, Mol Cell Endocrinol, 60, 101, 10.1016/0303-7207(88)90124-4 · doi:10.1016/0303-7207(88)90124-4
  29. 1996, Prostate, 28, 219, 10.1002/(SICI)1097-0045(199604)28:4<219::AID-PROS2>3.0.CO;2-8 · doi:10.1002/(sici)1097-0045(199604)28:4<219::aid-pros2>3.0.co;2-8
  30. 1995, Microsc Res Tech, 30, 333, 10.1002/jemt.1070300408 · doi:10.1002/jemt.1070300408
  31. 1996, Int J Cancer, 67, 573, 10.1002/(SICI)1097-0215(19960807)67:4<573::AID-IJC17>3.0.CO;2-8 · doi:10.1002/(sici)1097-0215(19960807)67:4<573::aid-ijc17>3.0.co;2-8
  32. 1990, Cancer Res, 90, 3748
  33. 1985, Cancer Surv, 4, 683
  34. 1993, Hum Pathol, 24, 4, 10.1016/0046-8177(93)90055-L · DOI · Paper page
  35. 1996, Urol Oncol, 2, 131, 10.1016/S1078-1439(96)00078-6 · DOI
  36. 1991, Mol Endocrinol, 5, 503, 10.1210/mend-5-4-503 · doi:10.1210/mend-5-4-503
  37. 1996, Cancer Res, 56, 3359
  38. 1992, Mol Endocrinol, 6, 15
  39. 1996, Cancer Res, 56, 44
  40. 1996, Clin Cancer Res, 2, 1255
  41. 1995, Urol Oncol, 1, 252, 10.1016/1078-1439(96)00028-2 · DOI
  42. 1990, Ann N Y Acad Sci, 580, 225, 10.1111/j.1749-6632.1990.tb17931.x · DOI · Paper page
  43. 1988, FASEB J, 2, A875
  44. 1995, Acta Pathol Microbiol Immunol Scand, 103, 140, 10.1111/j.1699-0463.1995.tb01089.x · DOI
  45. 1992, Endocrinology, 130, 2955, 10.1210/endo.130.5.1374018 · DOI
  46. 1989, Prostate, 15, 355, 10.1002/pros.2990150408 · doi:10.1002/pros.2990150408
  47. 1992, Cancer Res, 52, 571
  48. 1993, Mol Cell Biol, 13, 4513, 10.1128/MCB.13.8.4513 · DOI · Paper page
  49. 1990, EMBO J, 9, 907, 10.1002/j.1460-2075.1990.tb08188.x · DOI · Paper page
  50. 1990, J Natl Cancer Inst, 82, 4, 10.1093/jnci/82.1.4 · DOI · Paper page
  51. 1989, Cancer Res, 49, 2485
  52. 1991, Cancer Surv, 11, 165
  53. 1992, Mol Endocrinol, 6, 2123
  54. 1992, Proc Natl Acad Sci U S A, 89, 3305, 10.1073/pnas.89.8.3305 · DOI
  55. 1995, Exp Mol Pathol, 63, 52, 10.1006/exmp.1995.1030 · doi:10.1006/exmp.1995.1030
  56. 1997, Oncogene, 15, 1115, 10.1038/sj.onc.1201256 · doi:10.1038/sj.onc.1201256
  57. 1996, J Steroid Biochem Mol Biol, 57, 173, 10.1016/0960-0760(95)00259-6 · doi:10.1016/0960-0760(95)00259-6
  58. 1991, J Clin Endocrinol Metab, 73, 401, 10.1210/jcem-73-2-401 · DOI · Paper page
  59. 1996, J Clin Endocrinol Metab, 81, 612
  60. 1996, Int J Urol, 3, 39, 10.1111/j.1442-2042.1996.tb00628.x · DOI
  61. 1993, J Clin Endocrinol Metab, 77, 229
  62. 1995, Endocrinology, 136, 1040, 10.1210/endo.136.3.7532576 · DOI
  63. 1996, Eur J Endocrinol, 134, 591, 10.1530/eje.0.1340591 · DOI
  64. 1986, Clin Sci, 70, 359, 10.1042/cs0700359 · doi:10.1042/cs0700359
  65. 1988, Mol Cell Endocrinol, 56, 21, 10.1016/0303-7207(88)90004-4 · DOI
  66. 1988, Biochem Int, 17, 311
  67. 1996, Prostate, 28, 139, 10.1002/(SICI)1097-0045(199603)28:3<139::AID-PROS1>3.0.CO;2-A · doi:10.1002/(sici)1097-0045(199603)28:3<139::aid-pros1>3.0.co;2-a
  68. 1988, J Urol, 139, 857, 10.1016/S0022-5347(17)42662-0 · doi:10.1016/s0022-5347(17)42662-0
  69. 1993, Br J Cancer, 67, 152, 10.1038/bjc.1993.26 · doi:10.1038/bjc.1993.26
  70. 1993, Prostate, 23, 9, 10.1002/pros.2990230103 · doi:10.1002/pros.2990230103
  71. 1996, Hum Pathol, 27, 688, 10.1016/S0046-8177(96)90399-8 · DOI
  72. 1994, J Urol, 152, 2120, 10.1016/S0022-5347(17)32335-2 · DOI
  73. 1994, Prostate, 24, 46, 10.1002/pros.2990240110 · DOI
  74. 1996, Int J Urol, 3, 39, 10.1111/j.1442-2042.1996.tb00628.x · DOI
  75. 1994, Prostate, 24, 204, 10.1002/pros.2990240406 · DOI
  76. 1992, J Urol, 147, 1444, 10.1016/S0022-5347(17)37590-0 · DOI
  77. 1992, Cancer Res, 52, 5403
  78. 1995, Urology, 45, 542, 10.1016/S0090-4295(99)80034-X · DOI · Paper page
  79. 1994, J Urol, 151, 1396, 10.1016/S0022-5347(17)35267-9 · DOI
  80. 1980, Prog Clin Biol Res, 37, 379
  81. 1963, Natl Cancer Inst Monogr, 12, 351
  82. 1987, Current approaches to the study of prostate cancer, 513
  83. 1975, Cancer Res, 35, 1840
  84. 1986, Prostate, 9, 261, 10.1002/pros.2990090306 · DOI · Paper page
  85. 1975, Cancer Res, 35, 2935
  86. 1977, Cancer Res, 37, 1929
  87. 1980, Prog Clin Biol Res, 37, 325
  88. 1985, Anticancer Res, 5, 193
  89. 1989, Int J Cancer, 43, 1179, 10.1002/ijc.2910430636 · DOI
  90. 1973, J Natl Cancer Inst, 51, 1235, 10.1093/jnci/51.4.1235 · doi:10.1093/jnci/51.4.1235
  91. 1985, Prostate, 6, 389, 10.1002/pros.2990060407 · doi:10.1002/pros.2990060407
  92. 1994, Cancer Res, 54, 626
  93. 1975, J Natl Cancer Inst, 55, 177, 10.1093/jnci/55.1.177 · doi:10.1093/jnci/55.1.177
  94. 1981, J Natl Cancer Inst, 66, 565
  95. 1964, Cancer Res, 25, 1168
  96. 1972, Biochem J, 127, 561, 10.1042/bj1270561 · doi:10.1042/bj1270561
  97. 1989, Cell, 56, 917, 10.1016/0092-8674(89)90625-9 · DOI · Paper page
  98. 1983, Tissue Antigens, 21, 227, 10.1111/j.1399-0039.1983.tb00162.x · doi:10.1111/j.1399-0039.1983.tb00162.x
  99. 1979, Invest Urol, 17, 16
  100. 1977, Cancer Res, 37, 4049
  101. 1980, Prog Clin Biol Res, 37, 115
  102. 1994, Int J Cancer, 57, 406, 10.1002/ijc.2910570319 · DOI · Paper page
  103. 1994, Cancer Res, 54, 2577
  104. 1996, Proc Natl Acad Sci U S A, 93, 11802, 10.1073/pnas.93.21.11802 · DOI · Paper page
  105. 1996, Cancer Res, 56, 3042
  106. 1980, Prostate, 1, 95, 10.1002/pros.2990010113 · DOI
  107. 1993, Prostate, 23, 149, 10.1002/pros.2990230208 · doi:10.1002/pros.2990230208
  108. 1984, J Urol, 132, 384, 10.1016/S0022-5347(17)49633-9 · DOI
  109. 1996, Int J Cancer, 67, 785, 10.1002/(SICI)1097-0215(19960917)67:6<785::AID-IJC6>3.0.CO;2-N · doi:10.1002/(sici)1097-0215(19960917)67:6<785::aid-ijc6>3.0.co;2-n
  110. 1987, Cancer Genet Cytogenet, 26, 165, 10.1016/0165-4608(87)90143-9 · doi:10.1016/0165-4608(87)90143-9
  111. 1988, Mol Cell Endocrinol, 55, 167, 10.1016/0303-7207(88)90131-1 · doi:10.1016/0303-7207(88)90131-1
  112. 1983, J Cell Biol, 96, 1662, 10.1083/jcb.96.6.1662 · DOI · Paper page
  113. 1990, J Steroid Biochem Mol Biol, 37, 843, 10.1016/0960-0760(90)90430-S · doi:10.1016/0960-0760(90)90430-s
  114. 1987, J Urol, 137, 1304, 10.1016/S0022-5347(17)44488-0 · DOI
  115. 1996, Clin Cancer Res, 2, 1627
  116. 1991, Cancer Res, 51, 3753
  117. 1992, J Urol, 147, 1151, 10.1016/S0022-5347(17)37506-7 · DOI · Paper page
  118. 1991, Cancer Surv, 11, 91
  119. 1993, Cancer Res, 53, 2852
  120. 1992, Endocrinology, 131, 3045, 10.1210/endo.131.6.1446639 · doi:10.1210/endo.131.6.1446639
  121. 1990, Cell, 61, 1121, 10.1016/0092-8674(90)90075-P · DOI · Paper page
  122. 1995, Proc Natl Acad Sci U S A, 92, 3439, 10.1073/pnas.92.8.3439 · DOI · Paper page
  123. 1996, Cancer Res, 56, 4894
  124. 1996, Cancer Res, 56, 4096
  125. 1990, Peptide growth factors and their receptors: handbook of experimental pharmacology. Volume 95–1, 419
  126. 1994, World J Urol, 12, 96
  127. 1989, Mol Endocrinol, 3, 1977, 10.1210/mend-3-12-1977 · DOI · Paper page
  128. 1990, Ann N Y Acad Sci, 593, 208, 10.1111/j.1749-6632.1990.tb16113.x · DOI
  129. 1993, Science, 260, 1335, 10.1126/science.8388126 · DOI · Paper page
  130. 1994, J Biol Chem, 269, 30688, 10.1016/S0021-9258(18)43868-9 · DOI
  131. 1995, Eur J Clin Invest, 25, 959, 10.1111/j.1365-2362.1995.tb01974.x · DOI
  132. 1997, Int J Hematol, 65, 97, 10.1016/S0925-5710(96)00542-7 · doi:10.1016/s0925-5710(96)00542-7
  133. 1990, J Biol Chem, 265, 21393, 10.1016/S0021-9258(18)45745-6 · DOI · Paper page
  134. 1990, J Biol Chem, 265, 7709, 10.1016/S0021-9258(19)38983-5 · DOI · Paper page
  135. 1984, Nature, 309, 418, 10.1038/309418a0 · DOI · Paper page
  136. 1991, Growth Factors, 4, 265, 10.3109/08977199109043912 · DOI · Paper page
  137. 1990, J Cell Physiol, 144, 108, 10.1002/jcp.1041440114 · DOI · Paper page
  138. 1990, Cancer Metastasis Rev, 9, 227, 10.1007/BF00046362 · doi:10.1007/bf00046362
  139. 1985, Science, 230, 1385, 10.1126/science.4071057 · DOI · Paper page
  140. 1991, In Vitro Cell Dev Biol, 27A, 437
  141. 1989, Science, 245, 752, 10.1126/science.2475908 · DOI · Paper page
  142. 1989, Endocr Rev, 10, 68, 10.1210/edrv-10-1-68 · DOI · Paper page
  143. 1989, Cell, 59, 235, 10.1016/0092-8674(89)90281-X · DOI · Paper page
  144. 1990, Recent Prog Horm Res, 46, 99
  145. 1991, Cancer Surv, 11, 147
  146. 1988, EMBO J, 7, 3737, 10.1002/j.1460-2075.1988.tb03257.x · DOI · Paper page
  147. 1989, EMBO J, 6, 1899
  148. 1990, Cell, 53, 515
  149. 1990, Cell, 62, 175, 10.1016/0092-8674(90)90251-9 · DOI · Paper page
  150. 1991, EMBO J, 10, 1091, 10.1002/j.1460-2075.1991.tb08049.x · DOI · Paper page
  151. 1993, Cancer Res, 53, 3193
  152. 1989, Mol Cell Endocrinol, 62, 79, 10.1016/0303-7207(89)90115-9 · doi:10.1016/0303-7207(89)90115-9
  153. 1987, Biochemistry, 26, 2406, 10.1021/bi00383a002 · doi:10.1021/bi00383a002
  154. 1989, Mol Cell Biol, 9, 5508, 10.1128/MCB.9.12.5508 · DOI · Paper page
  155. 1997, Clin Exp Metastasis, 15, 41
  156. 1984, Cancer Res, 44, 1998
  157. 1989, Growth Factors, 1, 237
  158. 1989, Urol Int, 44, 71, 10.1159/000281473 · doi:10.1159/000281473
  159. 1992, J Cell Biochem Suppl, 16, 99
  160. 1992, Cancer Res, 33, 1651
  161. 1990, Prostate, 16, 209, 10.1002/pros.2990160304 · DOI
  162. 1989, Prostate, 15, 177, 10.1002/pros.2990150211 · DOI
  163. 1992, Br J Cancer, 65, 177, 10.1038/bjc.1992.37 · doi:10.1038/bjc.1992.37
  164. 1993, Mol Cell Biochem, 126, 151, 10.1007/BF00925693 · DOI
  165. 1994, Steroids, 59, 412, 10.1016/0039-128X(94)90010-8 · doi:10.1016/0039-128x(94)90010-8
  166. 1994, Surg Oncol, 3, 237, 10.1016/0960-7404(94)90039-6 · doi:10.1016/0960-7404(94)90039-6
  167. 1992, Br J Cancer, 65, 177, 10.1038/bjc.1992.37 · doi:10.1038/bjc.1992.37
  168. 1994, Br J Urol, 74, 214, 10.1111/j.1464-410X.1994.tb16589.x · doi:10.1111/j.1464-410x.1994.tb16589.x
  169. 1994, Prostate, 25, 199, 10.1002/pros.2990250405 · doi:10.1002/pros.2990250405
  170. 1990, J Urol, 143, 1272, 10.1016/S0022-5347(17)40253-9 · DOI
  171. 1991, J Steroid Biochem Mol Biol, 40, 199, 10.1016/0960-0760(91)90183-6 · doi:10.1016/0960-0760(91)90183-6
  172. 1991, J Steroid Biochem Mol Biol, 40, 193, 10.1016/0960-0760(91)90182-5 · DOI
  173. 1996, Prostate, 28, 392, 10.1002/(SICI)1097-0045(199606)28:6<392::AID-PROS9>3.0.CO;2-C · DOI · Paper page
  174. 1991, Mol Cell Biol, 11, 4627, 10.1128/MCB.11.9.4627 · DOI · Paper page
  175. 1992, Mol Cell Biol, 12, 82, 10.1128/MCB.12.1.82 · DOI · Paper page
  176. 1992, J Neurosci, 12, 142, 10.1523/JNEUROSCI.12-01-00142.1992 · DOI · Paper page
  177. 1986, EMBO J, 5, 2523, 10.1002/j.1460-2075.1986.tb04530.x · DOI · Paper page
  178. 1991, Growth Factors, 4, 277, 10.3109/08977199109043913 · DOI
  179. 1985, Regul Pept, 12, 201, 10.1016/0167-0115(85)90061-8 · DOI
  180. 1987, Nature, 325, 257, 10.1038/325257a0 · DOI · Paper page
  181. 1987, Nature, 326, 197, 10.1038/326197a0 · DOI · Paper page
  182. 1987, Curr Eye Res, 6, 1165, 10.3109/02713688709034890 · doi:10.3109/02713688709034890
  183. 1987, J Cell Biol, 104, 635, 10.1083/jcb.104.3.635 · DOI · Paper page
  184. 1996, Prostate, 28, 352, 10.1002/(SICI)1097-0045(199606)28:6<352::AID-PROS3>3.0.CO;2-C · doi:10.1002/(sici)1097-0045(199606)28:6<352::aid-pros3>3.0.co;2-c
  185. 1993, Prostate, 22, 183, 10.1002/pros.2990220302 · DOI
  186. 1989, Cancer Res, 49, 5889
  187. 1992, J Steroid Biochem Mol Biol, 41, 659, 10.1016/0960-0760(92)90400-D · doi:10.1016/0960-0760(92)90400-d
  188. 1994, Prostate, 25, 206, 10.1002/pros.2990250406 · doi:10.1002/pros.2990250406
  189. 1993, Jpn J Cancer Res, 84, 1300, 10.1111/j.1349-7006.1993.tb02838.x · doi:10.1111/j.1349-7006.1993.tb02838.x
  190. 1993, Am J Pathol, 43, 401
  191. 1983, Cancer, 53, 246
  192. 1996, Int J Dev Biol, 40, 941
  193. 1994, Growth Factors, 10, 269, 10.3109/08977199409010993 · DOI
  194. 1996, Growth Regul, 6, 22
  195. 1993, Cancer Res, 53, 1102
  196. 1993, Prostate, 22, 243, 10.1002/pros.2990220307 · DOI · Paper page
  197. 1996, Endocrinology, 137, 2676, 10.1210/endo.137.7.8770886 · doi:10.1210/endo.137.7.8770886
  198. 1995, J Bone Miner Res, 10, 788, 10.1002/jbmr.5650100516 · doi:10.1002/jbmr.5650100516
  199. 1987, Nutr Cancer, 9, 123, 10.1080/01635588709513919 · DOI
  200. 1992, Mol Biol Cell, 3, 189, 10.1091/mbc.3.2.189 · DOI

200 of 228 shown

Cited by

See all 216

Metadata

Authors
Russell, P. J., Bennett, S., & Stricker, P.
Venue
Clinical Chemistry
Publisher
Oxford University Press (OUP)
Published
1998-04-01
Volume
44
Issue
4
Pages
705-723
ISSN
  • 0009-9147 (ISSN-L)
  • 1530-8561
DOI
10.1093/clinchem/44.4.705
OpenAlex
W4298355764
Cited by
216
References
0
FWCI
14.88
Type
journal article
Language
en
Open access
closed
Licence
academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Growth factor involvement in progression of prostate cancer. https://app.cochat.ai/papers/10.1093/clinchem/44.4.705
The paper
Russell, P. J., Bennett, S., & Stricker, P. (1998). Growth factor involvement in progression of prostate cancer. Clinical Chemistry. https://doi.org/10.1093/clinchem/44.4.705

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.